viously demonstrated that microtubule disruption impairs stimulation of glucose uptake in cardiomyocytes and that 9-cis retinoic acid (9cRA) treatment preserved both microtubule integrity and stimulated glucose transport. Herein we investigated whether 1) activation of the extracellular signal-regulated kinases (ERK1/2) is responsible for microtubule destabilization and 2) ERK1/2 inactivation may explain the positive effects of 9cRA on glucose uptake and microtubule stabilization. Adult rat cardiomyocytes in primary culture showed increased basal ERK1/2 phosphorylation. Cardiomyocytes exposed to inhibitors of the ERK1/2 kinase mitogen/extracellular signalregulated kinase (MEK) 1/2 had preserved microtubular scaffold, including microtubule-organizing centers (MTOC), together with increased insulin and metabolic stress-stimulated glucose transport as well as signaling, thus replicating the effects of 9cRA treatment. Although 9cRA treatment did not significantly reduce global ERK1/2 activation, it markedly reduced perinuclear-activated ERK1/2 at the location of MTOC. 9cRA also triggered relocation of the ERK1/2 phosphatase mitogen-activated protein kinase phosphatase-3 from the cytosol to the nucleus. These results indicate that, in cardiomyocytes, microtubule destabilization, leading to impaired stimulation of glucose transport, is mediated by ERK1/2 activation, impacting on the MTOC. 9cRA acid restores stimulated glucose transport indirectly through compartmentalized inactivation of ERK1/2. insulin resistance; cytoskeleton; mitogen-activated proten kinase; extracellular signal-regulated kinase 1/2 ALTHOUGH CARDIOMYOCYTES CHIEFLY derive energy for contractile activity from oxidation of fatty acids, glucose metabolism is of paramount importance for the maintenance of ionic homeostasis. This is particularly important in situations of metabolic stress, as is demonstrated by the poor postischemic recovery of function in hearts that do not express the insulinresponsive glucose transporter GLUT4 (33). Metabolic stress such as ischemia results in the activation of the AMP-activated protein kinase (AMPK), which senses the increased ADP-to-ATP ratio (29). Insulin and metabolic stress signaling converge onto the Rab GTPase-activating protein protein kinase B substrate of 160 kDa (AS160), which is a target for phosphorylation by both protein kinase B (Akt) and AMPK (18, 32). According to current models of insulin-stimulated GLUT4 translocation, AS160 is associated with the intracellular GLUT4-containing vesicles, where it keeps small G proteins of the Rab family in an inactive state (30). This inhibition is relieved when AS160 is phosphorylated by Akt and/or AMPK, thus permitting the translocation of GLUT4 to the plasma membrane and an increase in glucose uptake (30).
ALTHOUGH CARDIOMYOCYTES CHIEFLY derive energy for contractile activity from oxidation of fatty acids, glucose metabolism is of paramount importance for the maintenance of ionic homeostasis. This is particularly important in situations of metabolic stress, as is demonstrated by the poor postischemic recovery of function in hearts that do not express the insulinresponsive glucose transporter GLUT4 (33) . Metabolic stress such as ischemia results in the activation of the AMP-activated protein kinase (AMPK), which senses the increased ADP-to-ATP ratio (29) . Insulin and metabolic stress signaling converge onto the Rab GTPase-activating protein protein kinase B substrate of 160 kDa (AS160), which is a target for phosphorylation by both protein kinase B (Akt) and AMPK (18, 32) . According to current models of insulin-stimulated GLUT4 translocation, AS160 is associated with the intracellular GLUT4-containing vesicles, where it keeps small G proteins of the Rab family in an inactive state (30) . This inhibition is relieved when AS160 is phosphorylated by Akt and/or AMPK, thus permitting the translocation of GLUT4 to the plasma membrane and an increase in glucose uptake (30) .
To study mechanisms of glucose transport stimulation in cardiomyocytes, we have recently used a model of isolated cardiomyocytes in which insulin stimulation of glucose uptake is markedly reduced on day 2 and 3 of culture and recovers thereafter (19, 27) . Further studies indicated that stimulation of glucose transport by metabolic stress was also impaired, although the metabolic-sensing system was functioning normally (19) . Impaired glucose transport in response to both insulin and metabolic stress was associated with disruption of the cytoskeletal microtubular network. Preservation of the differentiation of cardiomyocytes with various nuclear receptor agonists, including 9-cis retinoic acid (9cRA), preserved the microtubular network and improved insulin-and metabolic stress-stimulated glucose transport. We could demonstrate that microtubules were crucially involved in conveying insulin-or metabolic stress-triggered signaling to AS160, a key protein in the regulation of GLUT4 translocation (19) . The mechanisms by which microtubules become disrupted in cultured cardiomyocytes and why they are preserved in the presence of 9cRA remain elusive. Activation of extracellular signal-regulated kinase (ERK) 1/2 mitogen-activated protein kinase (MAPK) occurs during cardiomyocyte isolation (20) and may impact on microtubule stability (4) . Retinoic acids in turn could accelerate ERK1/2 deactivation by enhancing expression of MAPK phosphatases (23) . Chronic ERK1/2 activation occurs in most models of cardiac hypertrophy (16), a condition often associated with insulin resistance (24, 25) , thus warranting in vitro examination of the consequences of chronic ERK1/2 activation on the mechanisms of stimulated glucose transport.
Therefore, the goal of the present study was to test the hypothesis that ERK1/2 activation is responsible for the microtubule disruption and impaired glucose uptake in cultured cardiomyocytes. For this purpose, we measured 2-deoxy-Dglucose (2-DG) uptake in adult rat cardiomyocytes left untreated or treated with 9cRA or with pharmacological mitogen/ extracellular signal-regulated kinase (MEK) 1/2 inhibitors. Furthermore, we investigated the effect of ERK1/2 inhibition on intracellular signaling in response to insulin and metabolic stress and on the morphology of the microtubular network.
MATERIALS AND METHODS

National Institutes of Health (NIH Publication No. 85-23, revised 1996).
Adult rat cardiomyocyte culture. Adult rat cardiomyocytes were isolated by retrograde perfusion of the hearts with collagenase (type II; Worthington) (7, 11) . Dishes were previously coated with 0.1% gelatin for 4 h and incubated overnight with culture medium containing 20% FCS. For immunofluorescence studies, cardiomyocytes were plated on laminin-coated glass cover slips. Cells were plated in M199 medium supplemented with 20 mM creatine, 100 M cytosine-␤-Darabinofuranoside, and 20% FCS. 9cRA (Sigma-Aldrich), U-0126 (Promega), or PD-98059 (Calbiochem) were added from 1,000ϫ ethanol or dimethyl sulfoxide (DMSO) stock solutions to the medium at the time of plating (day 0).
Determination of 2-DG uptake. Glucose transport was estimated by measuring 2-DG uptake, as previously described (19) . Briefly, cardiomyocytes were incubated in M199 containing 10 nM 2-[2, 6- 3 H]DG (1-2 Ci/ml) (GE Healthcare) at 37°C for 1 h, in the presence or absence of glucose transport agonists. The reaction was stopped by adding 0.4 mM phloretin, and the cells were washed three times with ice-cold PBS before lysis in 1 ml 0.1 M NaOH. Aliquots (20 l) were taken for protein content determination, and the remaining NaOH lysate was assayed for radioactivity in a TriCARB 1900 TR liquid scintillation analyzer (Packard). Glucose transport agonists used were insulin (10 Ϫ6 M) or oligomycin (10 Ϫ6 M) to induce metabolic stress. Results are expressed as fold stimulation of 2-DG uptake with respect to control unstimulated cardiomyocytes.
Separation of tubulin fractions for immunoblotting. Myocardial tubulin fractions were prepared as previously described (5, 31); briefly, cardiomyocytes were lysed in a microtubule stabilization buffer [50% glycerol, 5% DMSO, 10 mM Na2HPO4, 0.5 mM EGTA, and 0.5 mM MgSO 4] and centrifuged at 100,000 g for 20 min at room temperature. The supernatant was saved as the heterodimer fraction. The pellet was resuspended in 1% SDS buffer, boiled for 10 min, and centrifuged at 16,000 g, 4°C for 10 min. The supernatant was saved as the microtubule fraction. For subsequent gel electrophoresis, to compare the amount of tubulin in the heterodimer vs. microtubule fractions of a given sample, an equal proportion of the two fractions from the same sample was applied. For between-sample comparisons, an equal amount of protein from each was applied. Polymeric and heterodimeric tubulin fractions were quantified using Western Blot analysis with a mouse monoclonal antibody to ␣-tubulin (clone B-5-1-2; Sigma-Aldrich).
Intracellular signaling analysis. After preincubation in serum-free M199 for 30 min, in 6-cm dishes, cells were stimulated with glucose transport agonists for 10 min (insulin) or 20 min (oligomycin). Stimulations were terminated by three rinses in ice-cold PBS before solubilizing cells in 200 l lysis buffer containing 150 mM NaCl, 50 mM Tris·HCl (pH 7.5), 1 mM EDTA, 0.5% sodium deoxycholate, 1% Igepal CA 630, Halt protease and phosphatase inhibitor cocktail (Pierce, Thermo Scientific). Proteins (100 g) from each sample were separated in 8.75% SDS-PAGE gels and transferred to polyvinylidene difluoride membranes. Thereafter, Western blots were immunoprobed with antibodies for phosphorylated and total signaling intermediates. The following primary antibodies were used: ERK1/2, phospho-ERK1/2 (Thr 202 /Tyr 204 ), Akt, phospho-Akt (Ser 473 ), phospho-Akt (Thr 308 ), insulin receptor (IR) ␤, phospho-IR␤ (Tyr 1150/1151 ), and phospho-(Ser/Thr) Akt substrate from Cell Signaling Technologies; AS160 from Upstate Biotechnology; and mouse monoclonal antibody to ␣-tubulin (clone B-5-1-2; Sigma-Aldrich). Densitometric analysis of chemiluminescent signals captured on films was performed using the Image J software (National Institutes of Health, http://rsb.info.nih. gov/ij). Because in many cases phosphorylation of the signaling intermediates was not detectable in the control unstimulated condition, in each independent experiment, the highest level of phosphorylation in the control group was given the arbitrary value of one, and the density of other bands was expressed relative to that.
Immunofluorescence analysis of microtubules. Fixed cardiomyocytes were analyzed by immunofluorescence, as described previously (19) . Primary antibodies used were the mouse monoclonal antibody to ␣-tubulin and the rabbit antibodies to phospho-ERK1/2, MAP kinase phosphatases (MKP)-1, MKP-3, and ␥-tubulin (Abcam); secondary fluorescent-labeled antibodies were a goat anti-mouse Alexa Fluor 488 and a goat anti-rabbit Alexa Fluor 546 (Invitrogen). DNA was labeled with TO-PRO-3 iodide (Invitrogen). Confocal fluorescent images were captured with a Carl Zeiss LSM510 microscope. Onemicrometer-thick confocal slices running through at least one nucleus were usually acquired. Image luminosity and contrast were digitally enhanced with ImageJ, taking care to apply the same linear adjustments to images from different experimental groups (28) . Individual microtubule length was computed and normalized for cell area using a routine written for the MetaMorph software (Molecular Devices) by Sergei Startchik, University of Geneva School of Medicine Bioimaging Facility. Colocalization of ␥-and ␣-tubulin was visualized using a plug in for Image J written by Pierre Bourdoncle (Institut Jacques Monod, Service Imagerie, Paris; http://imagej.nih.gov/ij/plugins/ colocalization.html), using default settings.
Statistics. Data are presented as means Ϯ SE and were compared by ANOVA (Prism 4; GraphPad Software) followed by Bonferroni's post hoc test. Differences were considered significant when P Ͻ 0.05.
RESULTS
ERK1/2 inhibition improves insulin-and metabolic stressstimulated glucose uptake.
To determine the role of ERK1/2 activation in the resistance to the stimulation of glucose uptake by insulin and oligomycin, isolated cardiomyocytes were incubated for 3 days with the structurally unrelated MEK1/2 inhibitors U-0126 (12) and PD-98059 (10), and 2-DG uptake was measured (Fig. 1) . We observed that both MEK1/2 inhibitors significantly increased insulin-and oligomycin-stimulated 2-DG uptake. We also confirmed the previous observation (19) that 9cRA increased insulin-and oligomycin-stimulated 2-DG uptake. The effects of MEK1/2 inhibition on 2-DG uptake were comparable with those of 9cRA. To test the hypothesis that MEK1/2 inhibition and 9cRA act through the same mechanism(s), we measured 2-DG uptake in cardiomyocytes treated with both U-0126 and 9cRA. We observed no additive effect of these treatments; moreover, the response to the double treatment was equivalent to the effect of U-0126 alone. Nonetheless, the absence of additive effect could be due to cardiomyocytes reaching maximal possible stimulation of glucose uptake. To rule out this possibility, cardiomyocytes cultured with both U-0126 and 9cRA were stimulated concurrently with both insulin and oligomycin (Fig. 1B) . This resulted in a further, additive increase of 2-DG uptake, indicating that maximal glucose uptake was not reached in the previous set of experiments. Thus, this result suggests that 9cRA and MEK inhibi- tion impacts on the same pathway to increase stimulated 2-DG uptake.
ERK1/2 inhibition improves the insulin signaling pathway. Because ERK1/2 inhibition improved insulin-stimulated 2-DG uptake, we examined the effect of this inhibition on insulin signaling. Insulin-induced phosphorylation of IR␤ on Tyr 1150/ 1151 and of Akt on Thr 308 and on Ser 473 was improved by treatment with U-0126, similar to the situation in response to 9cRA (19) (Fig. 2) . The Rab GTPase-activating protein AS160 has been identified as a substrate of Akt (30) and of AMPK (32) , which upon phosphorylation dissociates from GLUT4- containing vesicles, allowing GLUT4 translocation. Chronic treatment with U-0126 or 9cRA resulted in increased phosphorylation of AS160 in response to insulin and to oligomycin compared with untreated cardiomyocytes. Because the effect of oligomycin on AS160 is mediated by AMPK activation, we examined the impact of U-0126 and 9cRA on AMPK phosphorylation level. We observed that U-0126 and 9cRA increased the basal and oligomycin-stimulated phospho-AMPK level. These results demonstrate that ERK1/2 inhibition improves insulin and metabolic stress signaling and thereby insulin-and oligomycin-stimulated 2-DG uptake.
ERK1/2 inhibition preserves microtubules. We have previously observed that, in cardiomyocytes, microtubules are important for oligomycin-and insulin-stimulated 2-DG uptake and that 9cRA improves oligomycin-and insulin-stimulated 2-DG uptake by preserving microtubule structure (19) . To further understand the mechanism of U-0126-mediated improvement of stimulated 2-DG uptake, we determined whether U-0126 treatment could preserve microtubule structure. In insulin-responsive cardiomyocytes cultured for 1 day, the microtubule network was well structured, and microtubule-organizing centers (MTOC) were present in the perinuclear region. By this time, neither U-0126 nor 9cRA had an effect on the microtubule network as shown by confocal images (Fig. 3A) . Insulin-unresponsive cardiomyocytes cultured for 3 days displayed disturbed microtubules with altered MTOC (Fig. 3B) . In contrast, U-0126-and 9cRA-treated cardiomyocytes exhibited a well-organized microtubule network, characterized by dense microtubules bundles and MTOC, the identity of which was confirmed by direct staining of the pericentriolar protein ␥-tubulin, with clear colocalization of ␥-tubulin and ␣-tubulin within the perinuclear area of treated cardiomyocytes (Fig.  3C) . In contrast, in the cytoplasm of untreated cardiomyocytes, ␥-tubulin was diffuse.
Microtubule preservation was confirmed by both morphometry and biochemistry analysis, which indicated that, in the presence of 9cRA or U-0126, both the mean microtubular length and the ratio of polymerized to heterodimeric tubulin were increased (Fig. 4) . Together these results suggest that, like 9cRA, U-0126 treatment preserves the microtubule network, thereby increasing insulin-and oligomycin-stimulated 2-DG uptake.
9cRA restricts perinuclear ERK1/2 activation. Because the effects of MEK1/2 inhibitors were comparable with those of 9cRA, we tested whether 9cRA acted through prevention of ERK1/2 activation. In untreated cardiomyocytes, the phosphorylation of ERK1/2 reached a maximum at day 1 and gradually decreased without returning to basal levels (20) . U-0126, used as positive control for inhibition of ERK1/2, strongly inhibited the phosphorylation of ERK1/2 at all times. 9cRA treatment blunted the peak of ERK1/2 phosphorylation occurring at day 1 (Fig. 5A) .
Because our data suggested that ERK1/2 activation could be responsible for the disruption of cytoskeletal organization and it had been reported that ERK1/2 associate with microtubules and cause microtubule alteration in fibroblasts (26), we compared the intracellular pattern of activated ERK1/2 immunofluorescence with that of microtubules in control and 9cRA-treated cardiomyocytes. The results showed in control cardiomyocytes cultured for 1 day intense nuclear phospho-ERK1/2 labeling as well as diffuse cytosolic phospho-ERK1/2 (Fig.  3A) . Overall, phospho-ERK1/2 was markedly inhibited in U-0126-treated cardiomyocytes. 9cRA treatment reduced nuclear but not cytoplasmic phospho-ERK1/2.
Remarkably, 3 days insulin-resistant untreated cardiomyocytes with faint or absent perinuclear MTOC and disturbed microtubular cytoskeleton displayed perinuclear localization of phospho-ERK1/2 (Fig. 3B) . No phospho-ERK1/2 was detectable in cardiomyocytes exposed to U-0126, which showed well-preserved microtubules and MTOC. Most interestingly, in cardiomyocytes exposed to 9cRA, cytosolic phospho-ERK1/2 remained, but perinuclear phospho-ERK1/2 was attenuated, whereas, similar to U-0126-treated cardiomyocytes, microtubules and MTOC were well organized. Thus it appears that the presence of perinuclear activated ERK1/2 precludes the maintenance of MTOC.
MKP are dual-specificity phosphatases that inactivate MAP kinases (13) . Retinoic acids can accelerate ERK1/2 deactivation by enhancing expression of MKP (23) . To determine whether the effect of 9cRA was mediated by MKP, we evaluated the protein expression level of MKP in cardiomyocytes treated with 9cRA for various times (Fig. 5) . The expression level of MKP-1 and MKP-3 was upregulated by 9cRA, but only significantly so after 3 days of incubation. 9cRA did not modulate MKP-2 expression (data not shown). Furthermore, there is subcellular differential regulation of ERK1/2 by MKP (13). Thus we have examined whether 9cRA affects MKP-1 and MKP-3 subcellular localization. No marked changes were observed in the mostly cytoplasmic localization of MKP-1 after 9cRA treatment (Fig. 6A) ; however, we observed that MKP-3, which was also mostly cytoplasmic in untreated cardiomyocytes, relocated to nuclei after 3 days of 9cRA treatment (Fig. 6B) .
DISCUSSION
Insulin and metabolic stress stimulate glucose uptake in cardiomyocytes mainly by triggering the translocation of the glucose transporter GLUT4 from intracellular compartments to the plasma membrane (8) . We have recently demonstrated that microtubules play a fundamental role in this process (19) . Here we show that activation of ERK1/2 is in part responsible for the microtubule disruption and insulin unresponsiveness in cultured cardiomyocytes. We also demonstrate that ERK1/2 inhibition restores well-structured microtubule cytoskeleton and improves insulin-and metabolic stress-stimulated glucose transport.
ERK1/2 activity and microtubule integrity. Activated ERK1/2 that remains in the cytoplasm can regulate microtubule dynamic by influencing the phosphorylation state of microtubule-associated proteins (MAP) (21) . ERK1/2 was also shown to associate with microtubules and directly modulate their dynamic (26) . Our previous results showed that ERK1/2 activation occurred during cardiomyocyte isolation (20) and that cultured cardiomyocytes developed insulin resistance and presented altered microtubules (19, 27 ). Therefore, we tested whether microtubules could be modulated by ERK1/2 activation. We found that pharmacological inhibition of MEK1/2, the ERK1/2-activating kinases, resulted in preserved microtubule architecture in cultured cardiomyocytes. Thus our results corroborate a recent study in which it has been shown that pharmacological inhibition of MEK1/2 increases microtubule stability in cardiomyocytes (4) . Nevertheless, in our case, we could not find differences in detyrosinated microtubule density between treated and untreated cardiomyocytes (data not shown).
ERK1/2 may either directly interact with microtubules or with other targets to regulate microtubule stability. To date, such targets in cardiomyocytes remain unknown to us. Activation of ERK1/2 may impact on microtubule stability by interfering with acetylation of tubulin (14) . We have, however, not observed any difference in acetyl-tubulin in our different culture conditions (data not shown). Recently, site-specific dephosphorylation of the microtubule-associated protein MAP4 has been shown to be the cause of excessive microtubule densification in the myocardium (6) . By contrast, one may speculate that hyperphosphorylation of MAP4 on these specific sites may lead to microtubule disruption. Although neither phosphorylation site described by Chinnakkannu and colleagues (6) lies within an ERK1/2 consensus target sequence, and indeed no such sequence is present in MAP4, phosphorylation of MAP4 by ERK1/2 has been observed previously (15) .
Regulation of ERK1/2 activation by retinoic acid. Retinoic acid modulates MAPK activity by enhancing MKP expression (23) . It is now assumed that MKP are key players for inactivating different MAPK isoforms (17) . We found that exposure of cardiomyocytes to 9cRA upregulated MKP-1 and MKP-3 in a time-dependent manner, which we could not completely correlate with the slight modulation of ERK1/2 phosphorylation observed by Western blot analysis. Furthermore, MKP expression occurred too late to explain the restoration of glucose transport stimulation, being only significant after 3 days of exposure to 9cRA, thus at a time at which the effect of 9cRA on microtubules has already fully manifested.
Western blotting allows only analyses of global variations of the phosphorylation of ERK1/2, thus not reflecting local variations. Using an immunofluorescence approach, we could observe perinuclear phosphorylated ERK1/2 in insulin-resistant cardiomyocytes presenting disrupted microtubules and absent MTOC. This finding raised the possibility that active ERK1/2 interacts with the MTOC and disturbs microtubule nucleation. Indeed, in 9cRA-treated cardiomyocytes, perinuclear phospho-ERK1/2 vanished, whereas phospho-ERK1/2 remained in the cytoplasm.
Effect of ERK1/2 inhibition on insulin signaling. We observed in this study a remarkable improvement of all stages of insulin signaling examined in cardiomyocytes with either pharmacological chronic inhibition of the ERK1/2 axis or exposure to 9cRA. In contrast, in previous studies, pharmacological disruption of microtubules reduced only AS160 phosphorylation and neither phosphorylation of IR␤ nor that of Akt (19, 22) . Thus it is possible that ERK1/2 inhibition, whether directly or through 9cRA-induced expression of MKP, positively impacts on proximal insulin signaling independent of its effects on microtubular architecture. Evidence from the literature strongly suggest that activated ERK1/2 can phosphorylate insulin receptor substrate-1 on Ser 616 (1, 2), a putative inactivating phosphorylation site. It remains, however, striking that the same level of improvement of insulin signaling is achieved with 9cRA despite a marginal inhibition of overall ERK1/2 activation, thus reinforcing our conclusion that inhibition of local, microtubule-associated ERK1/2 activity is of particular importance.
Untoward effects of pharmacological MEK1/2 inhibition. Despite being structurally unrelated, the two pharmacological MEK1/2 inhibitors used in this study, U-0126 and PD-98059, exert the same untoward effect: activation of the AMPK (9), which could explain the increased basal glucose uptake and AS160 phosphorylation observed in cardiomyocytes exposed to these compounds. Activation of AMPK has been reported to alleviate insulin resistance through insulin-independent activation of Akt in a different model of cardiomyocytes in primary culture (3). We do not, however, believe this mechanism to be operative in this study, since the basal levels of Akt phosphorylation remained very low in cardiomyocytes cultured in the presence of U-0126.
In summary, the present study confirms that intact microtubules are required for the transduction of the signal induced by insulin or metabolic stress in cardiomyocytes and indicates that microtubule organization is affected by the ERK1/2 MAPK activity.
